These studies have shown that inhibition of signaling through EGFR, RAS, PI3-Kinase, AKT, and mTOR results in enhanced vascular function, which may be one of the mechanisms by which inhibitors of these pathways radiosensitize tumor cells. This evidence concerns the gene EGFR and neoplasm.